Drugs / LIPO-6T
last change Feb 2004 re-read 2 minutes ago

LIPO-6T

Developed for
HIV infectious disease
Investigated by
Aventis Pharmaceuticals · French National Agency for Research on AIDS and Viral Hepatitis

Trials 1 · a red edge is where a trial was stopped

2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT00196651 Aug 2000 → Feb 2004 HIV infectious disease French National Agency for Research on AIDS and Viral Hepatitis Terminated No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as LIPO-6T ClinicalTrials.gov intervention name — accepted as the source's own label NCT00196651